Skip to Main Content
Table 2—

Baseline characteristics of type 2 diabetic patients

Control clinicsIntervention clinicsP value
n 3,131 3,970  
Age (years) 63.2 ± 0.92 62.4 ± 0.91 0.540 
Female sex (%) 50.5 49.0 0.531 
No. of physician visits 4.85 ± 0.28 4.41 ± 0.28 0.285 
No. of diabetes complications 0.23 ± 0.03 0.26 ± 0.02 0.463 
Nephropathy (%) 6.1 5.4 0.665 
Neuropathy (%) 11.4 11.9 0.765 
Retinopathy (%) 5.8 8.9 0.020* 
Myocardial infarction (%) 16.1 18.9 0.189 
Congestive heart failure (%) 4.2 3.4 0.352 
Peripheral vascular disease (%) 4.3 4.3 0.986 
Cerebrovascular disease (%) 5.3 6.5 0.106 
Average A1C (%) 7.33 7.25 0.411 
Average SBP (mmHg) 133.2 132.3 0.448 
Average LDL (mg/dl) 103.6 104.1 0.709 
Hypertension (SBP > 130 mmHg) (%) 68.6 70.4 0.526 
Hyperlipidemia (LDL > 100 mg/dl) (%) 60.4 61.9 0.758 
Charlson Comorbidity Index 1.70 ± 0.05 1.77 ± 0.04 0.283 
Control clinicsIntervention clinicsP value
n 3,131 3,970  
Age (years) 63.2 ± 0.92 62.4 ± 0.91 0.540 
Female sex (%) 50.5 49.0 0.531 
No. of physician visits 4.85 ± 0.28 4.41 ± 0.28 0.285 
No. of diabetes complications 0.23 ± 0.03 0.26 ± 0.02 0.463 
Nephropathy (%) 6.1 5.4 0.665 
Neuropathy (%) 11.4 11.9 0.765 
Retinopathy (%) 5.8 8.9 0.020* 
Myocardial infarction (%) 16.1 18.9 0.189 
Congestive heart failure (%) 4.2 3.4 0.352 
Peripheral vascular disease (%) 4.3 4.3 0.986 
Cerebrovascular disease (%) 5.3 6.5 0.106 
Average A1C (%) 7.33 7.25 0.411 
Average SBP (mmHg) 133.2 132.3 0.448 
Average LDL (mg/dl) 103.6 104.1 0.709 
Hypertension (SBP > 130 mmHg) (%) 68.6 70.4 0.526 
Hyperlipidemia (LDL > 100 mg/dl) (%) 60.4 61.9 0.758 
Charlson Comorbidity Index 1.70 ± 0.05 1.77 ± 0.04 0.283 

Data are means ± SEM unless indicated otherwise.

*

P < 0.05.

Close Modal

or Create an Account

Close Modal
Close Modal